Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

NYU seeks partner for novel antibacterial technology

Jan. 22, 1997

Olopatadine studied for allergic conjunctivitis

Jan. 20, 1997

Acular approved in U.S. for postoperative ocular inflammation

Jan. 7, 1997

Ciprofloxacin ophthalmic solution effective in treating bacterial corneal ulcers

Jan. 3, 1997

Pilocarpine TDS shows antiglaucoma activity in patients

Jan. 2, 1997

Further approval for breakthrough glaucoma medication

Dec. 30, 1996

FDA ophthalmic devices committee meetings scheduled for January

Dec. 24, 1996

NIH offers anticataract invention for licensing

Dec. 20, 1996

DuPont Merck reports ester prodrugs for glaucoma

Dec. 19, 1996

VISX supplemental PMA slated for review

Dec. 12, 1996

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...